← Back
$RAPP All transactions

Rapport Therapeutics, Inc.

▲ BUY
8 / 10

Conviction

$ Value

$499K

Shares

20,400

Price

$24

Filed

Sep 15

Why this score? (8/10)
  • Open market buy (+3)
  • Trade value >= $250K (+1)
  • Director (+1)
  • Cluster: 3 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Huber Reid M

Title

CIK

0001607052

Roles

Director

Transaction Details

Transaction Date

2025-09-12

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

20,400

Footnotes

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $24.23 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.

Filing Info

Accession No.

0001193125-25-203540

Form Type

4

Issuer CIK

0002012593

Huber Reid M's History

Date Ticker Type Value
2025-09-12 RAPP $499K
2025-08-19 CRGX D
2025-06-18 CRGX A $0
2025-06-17 RAPP A $0

Other Insiders at RAPP (90d)

Insider Bought Sold Last
Ignelzi Troy A.
Chief Financial Officer
2026-02-02
Ceesay Abraham
Chief Executive Officer
$320K 2026-02-18
Third Rock Ventures V, L.P. $17.2M 2026-04-17
Sevigny Jeffrey
Chief Medical Officer
2026-02-02
Gault Cheryl
Chief Operating Officer
$340K 2026-03-30
Bredt David
Chief Scientific Officer
$247K 2026-02-19
Yeleswaram Krishnaswamy
Chief Development Officer
$1.8M 2026-04-17